2013
DOI: 10.1016/j.earlhumdev.2013.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Intra-uterine exposure to maternal opiate abuse and HIV: The impact on the developing nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
14
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
1

Relationship

5
2

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 42 publications
2
14
0
Order By: Relevance
“…The predictive power of abnormal fidgety movements is known to be low, 8,9 although a considerable number of infants with abnormal fidgety movements were described among individuals prenatally exposed to maternal opiate abuse and/or HIV who ultimately developed various neurodevelopmental and psychiatric impairments. 30 …”
Section: Discussionmentioning
confidence: 99%
“…The predictive power of abnormal fidgety movements is known to be low, 8,9 although a considerable number of infants with abnormal fidgety movements were described among individuals prenatally exposed to maternal opiate abuse and/or HIV who ultimately developed various neurodevelopmental and psychiatric impairments. 30 …”
Section: Discussionmentioning
confidence: 99%
“…20 Abnormal FMs have been described in infants with trisomy 21 (Down syndrome) 21,22 and infants intra-uterinely exposed to maternal opiate abuse and/or HIV. 23 The predictive value of abnormal FMs is low. Infants with abnormal FMs may develop normally, 6,18,24,25 but could also develop CP.…”
Section: Normal Fmsmentioning
confidence: 96%
“…Specifically, the absence of fidgety movements (at 3–5 months) is typically associated with the development of cerebral palsy [37, 41, 42]. In addition to its application in infants with perinatal brain injury, the general movement assessment (GMA) has also been applied to—for example—intrauterine HIV-exposed and/or HIV-infected newborns and young infants [43], infants of mothers with ZIKV infection [44], infants with metabolic disorders [45], infants with genetic disorders [4649] and infants with ASD [50•, 51]. …”
Section: Introductionmentioning
confidence: 99%